These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17927719)

  • 1. Stability and activity in sputum of G10KHc, a potent anti-Pseudomonas antimicrobial peptide.
    Eckert R; Mchardy I; Yarbrough DK; He J; Qi F; Anderson MH; Shi W
    Chem Biol Drug Des; 2007 Nov; 70(5):456-60. PubMed ID: 17927719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin.
    Eckert R; Brady KM; Greenberg EP; Qi F; Yarbrough DK; He J; McHardy I; Anderson MH; Shi W
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3833-8. PubMed ID: 16940063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients.
    Sajjan US; Tran LT; Sole N; Rovaldi C; Akiyama A; Friden PM; Forstner JF; Rothstein DM
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3437-44. PubMed ID: 11709321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients.
    Aichele D; Schnare M; Saake M; Röllinghoff M; Gessner A
    Infect Immun; 2006 Aug; 74(8):4708-14. PubMed ID: 16861658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa.
    Alipour M; Suntres ZE; Omri A
    J Antimicrob Chemother; 2009 Aug; 64(2):317-25. PubMed ID: 19465435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence requirements and an optimization strategy for short antimicrobial peptides.
    Hilpert K; Elliott MR; Volkmer-Engert R; Henklein P; Donini O; Zhou Q; Winkler DF; Hancock RE
    Chem Biol; 2006 Oct; 13(10):1101-7. PubMed ID: 17052614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum.
    Bucki R; Sostarecz AG; Byfield FJ; Savage PB; Janmey PA
    J Antimicrob Chemother; 2007 Sep; 60(3):535-45. PubMed ID: 17584802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the antimicrobial activities of a chemokine-derived peptide (CDAP-4) on Pseudomonas aeruginosa.
    Martínez-Becerra F; Silva DA; Domínguez-Ramírez L; Mendoza-Hernández G; López-Vidal Y; Soldevila G; García-Zepeda EA
    Biochem Biophys Res Commun; 2007 Apr; 355(2):352-8. PubMed ID: 17307153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media.
    Perry JD; Laine L; Hughes S; Nicholson A; Galloway A; Gould FK
    J Antimicrob Chemother; 2008 May; 61(5):1057-61. PubMed ID: 18316821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to dermcidin-derived peptides is independent of bacterial protease activity.
    Senyürek I; Döring G; Kalbacher H; Deeg M; Peschel A; Wolz C; Schittek B
    Int J Antimicrob Agents; 2009 Jul; 34(1):86-90. PubMed ID: 19201578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs.
    Cherkasov A; Hilpert K; Jenssen H; Fjell CD; Waldbrook M; Mullaly SC; Volkmer R; Hancock RE
    ACS Chem Biol; 2009 Jan; 4(1):65-74. PubMed ID: 19055425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.
    Cerovský V; Slaninová J; Fucík V; Hulacová H; Borovicková L; Jezek R; Bednárová L
    Peptides; 2008 Jun; 29(6):992-1003. PubMed ID: 18375018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.
    Halwani M; Yebio B; Suntres ZE; Alipour M; Azghani AO; Omri A
    J Antimicrob Chemother; 2008 Dec; 62(6):1291-7. PubMed ID: 18931388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics.
    Cassone M; Vogiatzi P; La Montagna R; De Olivier Inacio V; Cudic P; Wade JD; Otvos L
    Peptides; 2008 Nov; 29(11):1878-86. PubMed ID: 18721837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa.
    Halwani M; Hebert S; Suntres ZE; Lafrenie RM; Azghani AO; Omri A
    Int J Pharm; 2009 May; 373(1-2):141-6. PubMed ID: 19429299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane interactions of designed cationic antimicrobial peptides: the two thresholds.
    Glukhov E; Burrows LL; Deber CM
    Biopolymers; 2008 May; 89(5):360-71. PubMed ID: 18186149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.
    Wolter DJ; Acquazzino D; Goering RV; Sammut P; Khalaf N; Hanson ND
    Clin Infect Dis; 2008 Jun; 46(12):e137-41. PubMed ID: 18462098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity.
    Nan YH; Bang JK; Shin SY
    Peptides; 2009 May; 30(5):832-8. PubMed ID: 19428758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity and protease stability of peptides containing fluorinated amino acids.
    Meng H; Kumar K
    J Am Chem Soc; 2007 Dec; 129(50):15615-22. PubMed ID: 18041836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.